A Binding Site on IL-17A for Inhibitory Macrocycles Revealed by Hydrogen/Deuterium Exchange Mass Spectrometry.

Computational assessment of the IL-17A structure identified two distinct binding pockets, the β-hairpin pocket and the α-helix pocket. The β-hairpin pocket was hypothesized to be the site of binding for peptide macrocycles. Support for this hypothesis was obtained using HDX-MS which revealed protection to exchange only within the β-hairpin pocket. This data represents the first direct structural evidence of a small molecule binding site on IL-17A that functions to disrupt the interaction with its receptor.

[1]  S. Tuske,et al.  Structure of IL-17A in complex with a potent, fully human neutralizing antibody. , 2009, Journal of molecular biology.

[2]  Guangjie Chen,et al.  Interleukin-17C promotes Th17 cell responses and autoimmune disease via interleukin-17 receptor E. , 2011, Immunity.

[3]  Xi Song,et al.  Crystal structures of interleukin 17A and its complex with IL-17 receptor A , 2013, Nature Communications.

[4]  J. Derry,et al.  Cutting Edge: Interleukin 17 Signals through a Heteromeric Receptor Complex , 2006, The Journal of Immunology.

[5]  A. Maitra,et al.  Cutting Edge: Identification of a Pre-Ligand Assembly Domain (PLAD) and Ligand Binding Site in the IL-17 Receptor1 , 2007, The Journal of Immunology.

[6]  S. Gaffen,et al.  Interleukin-17: a new paradigm in inflammation, autoimmunity, and therapy. , 2007, Journal of periodontology.

[7]  C. Dong,et al.  Signaling of interleukin-17 family cytokines in immunity and inflammation. , 2011, Cellular signalling.

[8]  D. M. van der Heijde,et al.  Efficacy and safety of secukinumab, a fully human anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-blind, placebo-controlled, phase II proof-of-concept trial , 2013, Annals of the rheumatic diseases.

[9]  Ying Wang,et al.  A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17 , 2005, Nature Immunology.

[10]  John R. Engen,et al.  Applications of Hydrogen/Deuterium Exchange MS from 2012 to 2014 , 2014, Analytical chemistry.

[11]  Jim Hu,et al.  IL-17RD (Sef or IL-17RLM) interacts with IL-17 receptor and mediates IL-17 signaling , 2009, Cell Research.

[12]  Thomas A. Halgren,et al.  Identifying and Characterizing Binding Sites and Assessing Druggability , 2009, J. Chem. Inf. Model..

[13]  C. Sasakawa,et al.  Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses. , 2009, Immunity.

[14]  W. Jin,et al.  IL-17 cytokines in immunity and inflammation , 2013, Emerging Microbes & Infections.

[15]  E. Rickel,et al.  Identification of Functional Roles for Both IL-17RB and IL-17RA in Mediating IL-25-Induced Activities , 2008, The Journal of Immunology.

[16]  J. Ortonne,et al.  Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis. , 2012, The New England journal of medicine.

[17]  Jun Zhang,et al.  HDX reveals unique fragment ligands for the vitamin D receptor. , 2014, Bioorganic & medicinal chemistry letters.

[18]  Subhashis Banerjee,et al.  Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis. , 2012, The New England journal of medicine.

[19]  S. Gaffen.  Structure and signalling in the IL-17 receptor family , 2009, Nature Reviews Immunology.

[20]  M. Seldin,et al.  Herpesvirus saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. , 1995, Journal of immunology.

[21]  E. Soriano,et al.  Hydrogen/deuterium exchange-protected oligomers populated during Aβ fibril formation correlate with neuronal cell death. , 2014, ACS chemical biology.

[22]  M. J. Chalmers,et al.  HDX Workbench: Software for the Analysis of H/D Exchange MS Data , 2012, Journal of The American Society for Mass Spectrometry.

[23]  C. Dong.  Genetic controls of Th17 cell differentiation and plasticity , 2011, Experimental & Molecular Medicine.

[24]  B. Kirkham,et al.  Interleukin‐17A: a unique pathway in immune‐mediated diseases: psoriasis, psoriatic arthritis and rheumatoid arthritis , 2014, Immunology.

[25]  Yoichiro Iwakura,et al.  Review Functional Specialization of Interleukin-17 Family Members , 2022 .

[26]  M. Fei,et al.  IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia , 2008, Nature Medicine.

[27]  A. Regev,et al.  Induction and molecular signature of pathogenic TH17 cells , 2012, Nature Immunology.

[28]  Frann Bennett,et al.  The Human IL-17F/IL-17A Heterodimeric Cytokine Signals through the IL-17RA/IL-17RC Receptor Complex , 2008, The Journal of Immunology.

[29]  Scott A. Busby,et al.  Differential hydrogen/deuterium exchange mass spectrometry analysis of protein–ligand interactions , 2011, Expert review of proteomics.

[30]  L. K. Ely,et al.  Structural basis of receptor sharing by interleukin 17 cytokines , 2009, Nature Immunology.

[31]  J. Ross,et al.  Identification of an Interleukin 17F/17A Heterodimer in Activated Human CD4+ T Cells* , 2007, Journal of Biological Chemistry.

[32]  A. Andoh,et al.  Increased expression of interleukin 17 in inflammatory bowel disease , 2003, Gut.

[33]  L. Joosten,et al.  Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. , 2004, Arthritis and rheumatism.

[34]  W. Ouyang,et al.  IL-17RC Is Required for Immune Signaling via an Extended SEF/IL-17R Signaling Domain in the Cytoplasmic Tail , 2010, The Journal of Immunology.

[35]  E. Pietras,et al.  IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice. , 2010, The Journal of clinical investigation.